Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis

doi:10.3748/wjg.v13.i23.3232

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3436)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

380

HTML

2745

Figures (1-2)

152

Tables (1-3)

159

Sum=3436

Jun 21, 2007 (publication date) through Sep 18, 2024

Times Cited of This Article

Times Cited (87)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 21, 2007; 13(23): 3232-3236
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3232

Open in New Tab Full Size Figure Download Figure

Figure 1 Plasma concentration of alanine aminotransferase in 9 patients with AIH before after 18 (range 12-37) mo treatment with tacrolimus in addition to prednisolone and azathioprin or mycophenolate mofetil.

Open in New Tab Full Size Figure Download Figure

Figure 2 Effect of tacrolimus therapy on inflammatory activity (A) and fibrosis score (B) at baseline and at the time of follow-up [18 (12-37) mo] in 9 patients with autoimmune hepatitis.

Citation: Larsen FS, Vainer B, Eefsen M, Bjerring PN, Hansen BA. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol 2007; 13(23): 3232-3236
URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3232.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i23.3232